Corneal Donor Material Selection

Michael D. Wagoner, Claes H. Dohlman, Daniel Albert, Philip Lavin, Alma Murphy, Maureen O'Neill-Dryja

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The authors conducted the first long-range study to demonstrate possible negative effects on he recipients of corneal transplantation from donors who had died of a systemic malignancy or of chronic neurologic disease. The results are reported of a long-term retrospective analysis of 73 patients who received 86 grafts from donors with various systemic malignancies. These patients were followed for a mean of 127 months. There was no evidence of the transfer of the same malignancy to any of the recipients. There was no increased incidence of malignancy or earlier mortality in our patient population when compared with a reference population. Graft infection, endophthalmitis, or local tumor growth was not observed. The authors state that at the present time there is no basis for excluding donors dying of systemic malignancy as a source of material for use in keratoplasty. The authors examined the case histories of six patients who received grafts from donors who had died of a neurological disease with a suspected viral etiology. In a follow-up period ranging from 120 to 174 months, no evidence of neurologic disease developed in any of the patients. The sample was too small to provide data necessary for drawing conclusions concerning the safety of the use of material from this source. The authors strongly advise excluding any patient with a neurologic disease of suspected viral etiology as a source of corneal donor material.

Original languageEnglish (US)
Pages (from-to)139-145
Number of pages7
JournalOphthalmology
Volume88
Issue number2
DOIs
StatePublished - Jan 1 1981
Externally publishedYes

Fingerprint

Donor Selection
Tissue Donors
Nervous System Diseases
Neoplasms
Corneal Transplantation
Transplants
Endophthalmitis
Population
Chronic Disease
Safety
Mortality
Incidence
Growth
Infection

Keywords

  • chronic neurologic disease
  • corneal transplantation
  • hematologic malignancy
  • Jakob-Creutzfeldt disease
  • metastatic carcinoma
  • rabies

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Wagoner, M. D., Dohlman, C. H., Albert, D., Lavin, P., Murphy, A., & O'Neill-Dryja, M. (1981). Corneal Donor Material Selection. Ophthalmology, 88(2), 139-145. https://doi.org/10.1016/S0161-6420(81)35070-2

Corneal Donor Material Selection. / Wagoner, Michael D.; Dohlman, Claes H.; Albert, Daniel; Lavin, Philip; Murphy, Alma; O'Neill-Dryja, Maureen.

In: Ophthalmology, Vol. 88, No. 2, 01.01.1981, p. 139-145.

Research output: Contribution to journalArticle

Wagoner, MD, Dohlman, CH, Albert, D, Lavin, P, Murphy, A & O'Neill-Dryja, M 1981, 'Corneal Donor Material Selection', Ophthalmology, vol. 88, no. 2, pp. 139-145. https://doi.org/10.1016/S0161-6420(81)35070-2
Wagoner MD, Dohlman CH, Albert D, Lavin P, Murphy A, O'Neill-Dryja M. Corneal Donor Material Selection. Ophthalmology. 1981 Jan 1;88(2):139-145. https://doi.org/10.1016/S0161-6420(81)35070-2
Wagoner, Michael D. ; Dohlman, Claes H. ; Albert, Daniel ; Lavin, Philip ; Murphy, Alma ; O'Neill-Dryja, Maureen. / Corneal Donor Material Selection. In: Ophthalmology. 1981 ; Vol. 88, No. 2. pp. 139-145.
@article{474bd9d3640f471cad5cc8183543e656,
title = "Corneal Donor Material Selection",
abstract = "The authors conducted the first long-range study to demonstrate possible negative effects on he recipients of corneal transplantation from donors who had died of a systemic malignancy or of chronic neurologic disease. The results are reported of a long-term retrospective analysis of 73 patients who received 86 grafts from donors with various systemic malignancies. These patients were followed for a mean of 127 months. There was no evidence of the transfer of the same malignancy to any of the recipients. There was no increased incidence of malignancy or earlier mortality in our patient population when compared with a reference population. Graft infection, endophthalmitis, or local tumor growth was not observed. The authors state that at the present time there is no basis for excluding donors dying of systemic malignancy as a source of material for use in keratoplasty. The authors examined the case histories of six patients who received grafts from donors who had died of a neurological disease with a suspected viral etiology. In a follow-up period ranging from 120 to 174 months, no evidence of neurologic disease developed in any of the patients. The sample was too small to provide data necessary for drawing conclusions concerning the safety of the use of material from this source. The authors strongly advise excluding any patient with a neurologic disease of suspected viral etiology as a source of corneal donor material.",
keywords = "chronic neurologic disease, corneal transplantation, hematologic malignancy, Jakob-Creutzfeldt disease, metastatic carcinoma, rabies",
author = "Wagoner, {Michael D.} and Dohlman, {Claes H.} and Daniel Albert and Philip Lavin and Alma Murphy and Maureen O'Neill-Dryja",
year = "1981",
month = "1",
day = "1",
doi = "10.1016/S0161-6420(81)35070-2",
language = "English (US)",
volume = "88",
pages = "139--145",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Corneal Donor Material Selection

AU - Wagoner, Michael D.

AU - Dohlman, Claes H.

AU - Albert, Daniel

AU - Lavin, Philip

AU - Murphy, Alma

AU - O'Neill-Dryja, Maureen

PY - 1981/1/1

Y1 - 1981/1/1

N2 - The authors conducted the first long-range study to demonstrate possible negative effects on he recipients of corneal transplantation from donors who had died of a systemic malignancy or of chronic neurologic disease. The results are reported of a long-term retrospective analysis of 73 patients who received 86 grafts from donors with various systemic malignancies. These patients were followed for a mean of 127 months. There was no evidence of the transfer of the same malignancy to any of the recipients. There was no increased incidence of malignancy or earlier mortality in our patient population when compared with a reference population. Graft infection, endophthalmitis, or local tumor growth was not observed. The authors state that at the present time there is no basis for excluding donors dying of systemic malignancy as a source of material for use in keratoplasty. The authors examined the case histories of six patients who received grafts from donors who had died of a neurological disease with a suspected viral etiology. In a follow-up period ranging from 120 to 174 months, no evidence of neurologic disease developed in any of the patients. The sample was too small to provide data necessary for drawing conclusions concerning the safety of the use of material from this source. The authors strongly advise excluding any patient with a neurologic disease of suspected viral etiology as a source of corneal donor material.

AB - The authors conducted the first long-range study to demonstrate possible negative effects on he recipients of corneal transplantation from donors who had died of a systemic malignancy or of chronic neurologic disease. The results are reported of a long-term retrospective analysis of 73 patients who received 86 grafts from donors with various systemic malignancies. These patients were followed for a mean of 127 months. There was no evidence of the transfer of the same malignancy to any of the recipients. There was no increased incidence of malignancy or earlier mortality in our patient population when compared with a reference population. Graft infection, endophthalmitis, or local tumor growth was not observed. The authors state that at the present time there is no basis for excluding donors dying of systemic malignancy as a source of material for use in keratoplasty. The authors examined the case histories of six patients who received grafts from donors who had died of a neurological disease with a suspected viral etiology. In a follow-up period ranging from 120 to 174 months, no evidence of neurologic disease developed in any of the patients. The sample was too small to provide data necessary for drawing conclusions concerning the safety of the use of material from this source. The authors strongly advise excluding any patient with a neurologic disease of suspected viral etiology as a source of corneal donor material.

KW - chronic neurologic disease

KW - corneal transplantation

KW - hematologic malignancy

KW - Jakob-Creutzfeldt disease

KW - metastatic carcinoma

KW - rabies

UR - http://www.scopus.com/inward/record.url?scp=0019508851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019508851&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(81)35070-2

DO - 10.1016/S0161-6420(81)35070-2

M3 - Article

C2 - 7015217

AN - SCOPUS:0019508851

VL - 88

SP - 139

EP - 145

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 2

ER -